Interim results of the 5-box thoracoscopic maze procedure

John H Sirak1, David Schwartzman

  • 1Division of Cardiac Surgery, Ohio State University, Columbus, Ohio 43210, USA. johnsirak@gmail.com

Insights

This study demonstrates that a thoracoscopic Maze procedure effectively treats atrial fibrillation (AF) by isolating arrhythmogenic substrate. Patient outcomes show high rates of freedom from AF, achieving results comparable to traditional Maze surgery.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Electrophysiology
  • Minimally Invasive Procedures

Background:

  • Atrial fibrillation (AF) treatment requires comprehensive atrial lesion sets to prevent reentry and eliminate foci.
  • The Cox-Maze paradigm outlines critical surgical endpoints for AF ablation.
  • Previous closed-chest procedures have not fully incorporated all Cox-Maze endpoints.

Purpose of the Study:

  • To report patient outcomes of a totally thoracoscopic Maze procedure.
  • To evaluate the efficacy of a 5-box thoracoscopic Maze approach in treating drug-resistant AF.
  • To assess the feasibility of achieving Cox-Maze benchmark outcomes via a minimally invasive approach.

Main Methods:

  • 179 consecutive patients with drug-resistant AF underwent a 5-box thoracoscopic Maze procedure.
  • The procedure involved creating 5 discrete, contiguous left atrial compartments for isolation.
  • Postoperative surveillance included continuous ambulatory monitoring at set intervals.

Main Results:

  • High rates of freedom from AF were observed: 137/142 at 3 months, 115/119 at 6 months, 75/78 at 13 months, and 24/25 at 24 months.
  • Only one serious procedural complication occurred (pulmonary artery injury).
  • Two patients remained in sinus rhythm on low-dose antiarrhythmia therapy.

Conclusions:

  • A totally thoracoscopic Maze procedure effectively replicates the Cox-Maze lesion set, isolating arrhythmogenic substrate.
  • Meticulous verification of compartment integrity leads to outcomes equivalent to the Cox-Maze benchmark.
  • This minimally invasive approach offers a viable alternative for AF treatment.
Abstract